Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD)
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metabolic-associated fatty liver disease (MAFLD), also known as non-alcoholic fatty liver disease, has become the leading cause of chronic liver disease worldwide. In addition to hepatic accumulation of triglycerides, dysregulated cholesterol metabolism is an important contributor to the pathogenesis of MAFLD. Maintenance of cholesterol homeostasis is highly dependent on cellular cholesterol uptake and, subsequently, cholesterol transport to other membrane compartments, such as the endoplasmic reticulum (ER). SCOPE OF REVIEW: The endolysosomal network is key for regulating cellular homeostasis and adaptation, and emerging evidence has shown that the endolysosomal network is crucial to maintain metabolic homeostasis. In this review, we will summarize our current understanding of the role of the endolysosomal network in cholesterol homeostasis and its implications in MAFLD pathogenesis. MAJOR CONCLUSIONS: Although multiple endolysosomal proteins have been identified in the regulation of cholesterol uptake, intracellular transport, and degradation, their physiological role is incompletely understood. Further research should elucidate their role in controlling metabolic homeostasis and development of fatty liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Vanier, M. T. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-16 · Cited by 1,222
Rabs and their effectors: achieving specificity in membrane traffic
Grosshans, B. L., Ortiz, D., & Novick, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601617103 · Cited by 1,005 · cited 1×
“Specific Rabs are localized on each organelle and associated vesicles, where they act as molecular ‘on/off’ switches to interact with effectors and to regulate the assembly of protein machinery [68].”
BackgroundLXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
Zelcer, N., Hong, C., Boyadjian, R., & Tontonoz, P. (2009) · Science · doi:10.1126/science.1168974 · Cited by 848
Zhang, D.-W., Lagace, T. A., Garuti, R., Zhao, Z., McDonald, M., Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702027200 · Cited by 788 · cited 1×
“In the endosomes, PCSK9 prevents the acid-dependent conformational change of LDLR necessary for its recycling to the PM, thereby stimulating degradation of the receptor in the LE/LY [88,89].”
BackgroundSecreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice
Lagace, T. A., Curtis, D. E., Garuti, R., McNutt, M. C., Park, S. W., Prather, H. B., Anderson, N. N., Ho, Y. K., Hammer, R. E., & Horton, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29383 · Cited by 681 · cited 1×
“Extracellular binding of circulating PCSK9 to LDLR at the PM is followed by endocytosis of the PCSK9-LDLR complex, a process dependent on the adaptor protein ARH [86].”
BackgroundCargo-selective endosomal sorting for retrieval to the Golgi requires retromer
Seaman, M. N. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312034 · Cited by 624
To degrade or not to degrade: Mechanisms and significance of endocytic recycling
Cullen, P. J., & Steinberg, F. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0053-7 · Cited by 590
Structure of the LDL Receptor Extracellular Domain at Endosomal pH
Rudenko, G., Henry, L., Henderson, K., Ichtchenko, K., Brown, M. S., Goldstein, J. L., & Deisenhofer, J. (2002) · Science · doi:10.1126/science.1078124 · Cited by 482 · cited 1×
“Acidification of the endosomal lumen induces dissociation of LDL-cholesterol from LDLR, after which the receptor is either recycled back to the plasma membrane (PM) or directed to the lysosomes for degradation [19] (see also Section 6).”
BackgroundZavodszky, E., Seaman, M. N. J., Moreau, K., Jimenez-Sanchez, M., Breusegem, S. Y., Harbour, M. E., & Rubinsztein, D. C. (2014) · Nature Communications · doi:10.1038/ncomms4828 · Cited by 466 · cited 1×
“In addition, the Parkinson’s disease-related VPS35 mutation is associated with impaired autophagy, likely by decreased recruitment of the WASH complex to the endosomes, as loss of WASH in HeLa cells also results in a defect in autophagy [151].”
BackgroundRohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455 · cited 1×
“LRP1 cooperates with LDLR in the uptake of remnant lipoproteins [107], while SR-BI mediates the uptake of CE from high-density lipoprotein particles [108].”
BackgroundOrganization and Function of Membrane Contact Sites
Helle, S. C. J., Kanfer, G., Kolar, K., Lang, A., Michel, A. H., & Kornmann, B. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.01.028 · Cited by 453
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
Caballero, F., Fernández, A., De Lacy, A. M., Fernández-Checa, J. C., Caballería, J., & García-Ruiz, C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.016 · Cited by 368 · cited 1×
“Studies in patients have indicated that MAFLD is associated with upregulated SREBP expression [35,36], and data from mouse models demonstrate that increased activation of SREBP is a causal factor in the development and progression of fatty liver disease [37e40].”
BackgroundRab5 is necessary for the biogenesis of the endolysosomal system in vivo
Zeigerer, A., Gilleron, J., Bogorad, R. L., Marsico, G., Nonaka, H., Seifert, S., Epstein-Barash, H., Kuchimanchi, S., Peng, C. G., Ruda, V. M., et al. (2012) · Nature · doi:10.1038/nature11133 · Cited by 362 · cited 1×
“Rab5, a Rab protein localized to early endosomes (EE), is thought to be required for the biogenesis of the endolysosomal system in vivo and is downregulated in NASH patients [69,70].”
BackgroundRetriever is a multiprotein complex for retromer-independent endosomal cargo recycling
McNally, K. E., Faulkner, R., Steinberg, F., Gallon, M., Ghai, R., Pim, D., Langton, P., Pearson, N., Danson, C. M., Nägele, H., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3610 · Cited by 346 · cited 8×
“LRP1 cooperates with LDLR in the uptake of remnant lipoproteins [107], while SR-BI mediates the uptake of CE from high-density lipoprotein particles [108].”
BackgroundInfluentialMoon, Y.-A., Liang, G., Xie, X., Frank-Kamenetsky, M., Fitzgerald, K., Koteliansky, V., Brown, M. S., Goldstein, J. L., & Horton, J. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.017 · Cited by 320
Sandhu, J., Li, S., Fairall, L., Pfisterer, S. G., Gurnett, J. E., Xiao, X., Weston, T. A., Vashi, D., Ferrari, A., Orozco, J. L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.033 · Cited by 287 · cited 1×
“Gramd1b, also known as Aster-B, has also recently been implicated in PM-to-ER cholesterol transport [63,64].”
BackgroundLiao, G., Yao, Y., Liu, J., Yu, Z., Cheung, S., Xie, A., Liang, X., & Bi, X. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070052 · Cited by 220
CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL
Bartuzi, P., Billadeau, D. D., Favier, R., Rong, S., Dekker, D., Fedoseienko, A., Fieten, H., Wijers, M., Levels, J. H., Huijkman, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10961 · Cited by 205
Identification of Cholesterol-Regulating Genes by Targeted RNAi Screening
Bartz, F., Kern, L., Erz, D., Zhu, M., Gilbert, D., Meinhof, T., Wirkner, U., Erfle, H., Muckenthaler, M., Pepperkok, R., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.05.009 · Cited by 198 · cited 1×
“Previously, the membrane protein TMEM97 has been identified as an NPC1-interacting protein and regulator of cellular cholesterol levels [26].”
BackgroundKrahmer, N., Najafi, B., Schueder, F., Quagliarini, F., Steger, M., Seitz, S., Kasper, R., Salinas, F., Cox, J., Uhlenhaut, N. H., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.09.017 · Cited by 188 · cited 1×
“Further research is needed to enhance our understanding of their contribution to MAFLD and whether their functioning is affected by metabolic challenges [159].”
BackgroundMovement of accessible plasma membrane cholesterol by the GRAMD1 lipid transfer protein complex
Naito, T., Ercan, B., Krshnan, L., Triebl, A., Koh, D. H. Z., Wei, F.-Y., Tomizawa, K., Torta, F. T., Wenk, M. R., & Saheki, Y. (2019) · eLife · doi:10.7554/elife.51401 · Cited by 171 · cited 1×
“This pathway mediates the levels of accessible cholesterol in the PM and thus also the cholesterol levels in the ER, thereby regulating the activity of SREBP signaling [65,66].”
BackgroundSorting nexin 17 facilitates LRP recycling in the early endosome
van Kerkhof, P., Lee, J., McCormick, L., Tetrault, E., Lu, W., Schoenfish, M., Oorschot, V., Strous, G. J., Klumperman, J., & Bu, G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600756 · Cited by 148
Riad, A., Zeng, C., Weng, C.-C., Winters, H., Xu, K., Makvandi, M., Metz, T., Carlin, S., & Mach, R. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-35430-3 · Cited by 147
Rong, S., Cortés, V. A., Rashid, S., Anderson, N. N., McDonald, J. G., Liang, G., Moon, Y.-A., Hammer, R. E., & Horton, J. D. (2017) · eLife · doi:10.7554/elife.25015 · Cited by 134
Stockinger, W., Sailler, B., Strasser, V., Recheis, B., Fasching, D., Kahr, L., Schneider, W. J., & Nimpf, J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf435 · Cited by 130
Trinh, M. N., Brown, M. S., Goldstein, J. L., Han, J., Vale, G., McDonald, J. G., Seemann, J., Mendell, J. T., & Lu, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010682117 · Cited by 129
Fedoseienko, A., Wijers, M., Wolters, J. C., Dekker, D., Smit, M., Huijkman, N., Kloosterhuis, N., Klug, H., Schepers, A., Willems van Dijk, K., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312004 · Cited by 126
Singla, A., Fedoseienko, A., Giridharan, S. S. P., Overlee, B. L., Lopez, A., Jia, D., Song, J., Huff-Hardy, K., Weisman, L., Burstein, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12221-6 · Cited by 113 · cited 1×
“Recently, the CCC complex has been shown to regulate the level and activity of WASH on the endosomal compartment to control endosomal protein recycling [101].”
BackgroundBurden, J. J., Sun, X.-M., García, A. B. G., & Soutar, A. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313689200 · Cited by 82
Scotti, E., Calamai, M., Goulbourne, C. N., Zhang, L., Hong, C., Lin, R. R., Choi, J., Pilch, P. F., Fong, L. G., Zou, P., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01716-12 · Cited by 81
Aster Proteins Regulate the Accessible Cholesterol Pool in the Plasma Membrane
Ferrari, A., He, C., Kennelly, J. P., Sandhu, J., Xiao, X., Chi, X., Jiang, H., Young, S. G., & Tontonoz, P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00255-20 · Cited by 66 · cited 1×
“This pathway mediates the levels of accessible cholesterol in the PM and thus also the cholesterol levels in the ER, thereby regulating the activity of SREBP signaling [65,66].”
BackgroundCCDC22: a novel candidate gene for syndromic X-linked intellectual disability
Voineagu, I., Huang, L., Winden, K., Lazaro, M., Haan, E., Nelson, J., McGaughran, J., Nguyen, L. S., Friend, K., Hackett, A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.95 · Cited by 61 · cited 2×
“In humans, hypomorphic mutations in CCDC22 cause the severe developmental disorder X-linked intellectual disability (XLID) [103,104], and a homozygous splice site mutation in WASHC5 causes RitscherSchinzel Syndrome 1 [105], both severe developmental disorders.”
BackgroundRen, L., Sun, Y., Lu, H., Ye, D., Han, L., Wang, N., Daugherty, A., Li, F., Wang, M., Su, F., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312422 · Cited by 59 · cited 1×
“Furthermore, loss of the hepatic (pro)renin receptor reduces sortilindependent LDL uptake [157].”
BackgroundLoregger, A., Raaben, M., Nieuwenhuis, J., Tan, J. M. E., Jae, L. T., van den Hengel, L. G., Hendrix, S., van den Berg, M., Scheij, S., Song, J.-Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14811-1 · Cited by 51
POST1/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturation
Xiao, J., Xiong, Y., Yang, L.-T., Wang, J.-Q., Zhou, Z.-M., Dong, L.-W., Shi, X.-J., Zhao, X., Luo, J., & Song, B.-L. (2021) · Protein & Cell · doi:10.1007/s13238-020-00753-3 · Cited by 49 · cited 9×
“Data from Xiao et al. and Bayraktar et al. indicate that C12orf49 (renamed POST1) mediates SREBP activity through an interaction with site-1 protease (S1P), which cleaves SREBP at the Golgi, followed by a second cleavage of SREBP by site-2 protease (S2P) [44,45,47].”
BackgroundInfluentialThe hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126462 · Cited by 44 · cited 10×
“LRP1 cooperates with LDLR in the uptake of remnant lipoproteins [107], while SR-BI mediates the uptake of CE from high-density lipoprotein particles [108].”
BackgroundInfluentialSelf-citationSinning, D., & Landmesser, U. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01427-6 · Cited by 44 · cited 1×
“In addition to the inhibition of the extracellular binding of PCSK9 to LDLR through antibody-based therapies, blocking both the intracellular and the extracellular PCSK9-mediated LDLR degradation pathway by RNA-targeted therapy successfully lowers plasma LDL cholesterol and the risk of atherosclerotic cardiovascular d…”
BackgroundRimbert, A., Dalila, N., Wolters, J. C., Huijkman, N., Smit, M., Kloosterhuis, N., Riemsma, M., van der Veen, Y., Singla, A., van Dijk, F., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz727 · Cited by 24 · cited 2×
“Furthermore, a recent study revealed that a common genetic variant in CCDC93 in humans is associated with reduced plasma LDL cholesterol levels, and correlated with lower risk of myocardial infarction and cardiovascular mortality [106].”
Background
Cited by
Metabolic-associated fatty liver disease and lipoprotein metabolism
Heeren, J., & Scheja, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101238 · Cited by 646
Pathways and Mechanisms of Cellular Cholesterol Efflux—Insight From Imaging
Juhl, A. D., & Wüstner, D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.834408 · Cited by 57
Endosomal trafficking in metabolic homeostasis and diseases
Gilleron, J., & Zeigerer, A. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00737-9 · Cited by 57
Vos, D. Y., Wijers, M., Smit, M., Huijkman, N., Kloosterhuis, N. J., Wolters, J. C., Tissink, J. J., Pronk, A. C. M., Kooijman, S., Rensen, P. C. N., et al. (2023) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.122.318169 · Cited by 16
Self-citation
Metadata
- Authors
- Vos, D. Y., & van de Sluis, B.
- Venue
- Molecular Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 50
- Pages
- 101146
- ISSN
- 2212-8778 (ISSN-L)
- OpenAlex
- W3113749850
- Cited by
- 35
- References
- 40
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.